ARCHIVES

ASCO Picks Charles Balch To Succeed John Durant as Executive Vice President.

This article is from The Cancer Letter archive.

Vol. 26 No. 01 | January 7, 2000

Download PDF Visit The Full Archive

Related Articles

NIH Acting Director Kirschstein Preparing For Budget Hearings.

January 14, 2000

In Breif: FDA Issues Uterine Cancer-Tamoxifin Warning; Fisher Declined Invitation To Speak At AACR

April 15, 1994

Funding opportunities listed.

October 8, 2004

Research Regulation: NRC fines NIH for Not Securing Radioactive Materials

September 13, 1996

Abstracts Of Papers From ASCO Meeting

April 7, 1978

Patient Satisfaction Was Crucial In ODAC Review Of Panretin

November 27, 1998